Robert P. van Waateringe, from the University of Groningen in the Netherlands, and colleagues conducted a prospective analysis involving 72,880 participants from the Dutch Lifelines Cohort Study who had validated baseline skin autofluorescence values available and were not known to have diabetes or CVD. (HealthDay)—Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease (CVD), and...